Browsing: Novo Nordisk
People will keep eating Oreos despite Ozempic surge, according to CEO of maker, Mondelez
Even with appetite-suppressing drugs, people will keep eating Oreo cookies, according to the company that makes them. Mondelez International Inc.,…
Drug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked…
GLP-1s Like Ozempic, Wegovy Don’t Substantially Increase Thyroid Cancer Risk, Study Suggests
Topline Popular diabetes and weight loss drugs like Ozempic and Wegovy, known as GLP-1 medications, were not found to cause…
Study shows Wegovy eases heart-failure symptoms for patients with diabetes—helpful to Novo as it argues insurers should pay for it
Wegovy, the blockbuster weight-loss medication from Novo Nordisk A/S, eased heart-failure symptoms for patients with diabetes in the latest large trial…
The weight loss drug Wegovy secured a supplemental cardiovascular indication from the Food and Drug Administration last month. This allows…
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
Ozempic could be profitably produced for less than $5 a month even as maker Novo Nordisk A/S charges almost $1,000…
Ozempic maker Novo Nordisk has a new goal for its leadership team: Make sure no more than 10% of your staff are stressed
Workers today have much to be stressed out about; Geopolitical tensions are dominating their social media feeds, the cost of…
Ozempic Maker’s New Weight Loss Pill Beats Wegovy In Early Trial — What To Know About Novo Nordisk’s Amycretin
Topline Ozempic maker Novo Nordisk on Thursday teased a potential successor to its blockbuster weight loss drug Wegovy, the latest…
Merck Deal Boosts Founder Of Little-Known Korean Biotech Company Into Billionaire Ranks
Amid a frenzy for AI-related stocks, shares of a little-known biotech company in South Korea got an Nvidia-esque boost. Alteogen,…
Novo Nordisk CEO says he was ‘surprised’ to see the popularity of weight-loss drugs in Europe—and people’s readiness to pay out-of-pocket for them
The popularity of Novo Nordisk’s weight-loss drugs has been unprecedented and has shown no signs of fading. It’s clearly more…